Increased HLA class II risk is associated with a more aggressive presentation of clinical type 1 diabetes

被引:6
|
作者
Kielevainen, Vilma [1 ]
Turtinen, Maaret [2 ,3 ]
Luopajarvi, Kristiina [2 ,3 ]
Harkonen, Taina [3 ]
Ilonen, Jorma [4 ]
Knip, Mikael [2 ,3 ,5 ]
机构
[1] Univ Eastern Finland, Fac Hlth Sci, Kuopio, Finland
[2] Helsinki Univ Hosp, New Childrens Hosp, Pediat Res Ctr, Helsinki, Finland
[3] Univ Helsinki, Fac Med, Res Program Clin & Mol Metab, Helsinki, Finland
[4] Univ Turku, Inst Biomed, Immunogenet Lab, Turku, Finland
[5] Tampere Univ Hosp, Tampere Ctr Child Hlth Res, Tampere, Finland
关键词
clinical characteristics; diagnosis; HLA class II; type; 1; diabetes; BETA-CELL AUTOIMMUNITY; GENETIC SUSCEPTIBILITY; FAMILY-HISTORY; CHILDREN; KETOACIDOSIS; DIAGNOSIS; ONSET; CHILDHOOD; GENOTYPES; ALLELES;
D O I
10.1111/apa.16621
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Aim: To determine the association of HLA class II risk with the demographic and clinical characteristics of type 1 diabetes at diagnosis.Methods: We conducted a register- based retrospective cohort study of 4993 Finnish children (2169 girls) - diagnosed with type 1 diabetes under the age of 15 years in 2003- 2016. The participants were divided into six risk groups based on their HLA DR/DQ genotype. Demographic characteristics, family history of type 1 diabetes and metabolic markers at the time of diagnosis were compared between the groups.Results: In total, 4056/4993 children (81.2%) carried an HLA genotype associated with an increased risk of type 1 diabetes (risk groups 3- 5), whereas 937/4993 children (18.8%) carried a HLA genotype conferring no or decreased disease risk. Children with higher HLA risk were younger at diagnosis (p < 0.001) and had a shorter duration of classical symptoms before diagnosis (p = 0.016). Subjects in the high- risk group were more likely to have a family member affected by type 1 diabetes when compared to those in the neutral risk group (11.5% vs. 8.8%, p = 0.05).Conclusion: Children with stronger HLA disease susceptibility are younger at their disease manifestation and have a shorter period of symptoms before diagnosis, suggesting that the HLA class II genes are associated with a more aggressive disease presentation.
引用
收藏
页码:522 / 528
页数:7
相关论文
共 50 条
  • [41] Genetic susceptibility to type 1 diabetes in childhood - estimation of HLA class II associated disease risk and class II effect in various phases of islet autoimmunity (vol 17, pg 8, 2016)
    Ilonen, J.
    Kiviniemi, M.
    Lempainen, J.
    PEDIATRIC DIABETES, 2018, 19 (06) : 1131 - 1131
  • [42] Inhibitory KIRs decrease HLA class II-mediated protection in Type 1 Diabetes
    Mora-Bitria, Laura
    Debebe, Bisrat J.
    Miners, Kelly L.
    Ladell, Kristin
    Kaur, Charandeep
    Traherne, James A.
    Jiang, Wei
    Price, David A.
    Hadcocks, Linda
    Mcquibban, Nicholas A. R.
    Trowsdale, John
    Wong, F. Susan
    Pontikos, Nikolas
    Niederalt, Christoph
    Asquith, Becca
    PLOS GENETICS, 2024, 20 (12):
  • [43] Association of HLA Class II Alleles and CTLA-4 Polymorphism with Type 1 Diabetes
    Wafai, Rana J. Ei
    Chmaisse, Hania Nakkash
    Makki, Rajaa F.
    Fakhoury, Hana
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2011, 22 (02) : 273 - 281
  • [44] HLA class II is a factor in cardiovascular morbidity and mortality rates in patients with type 1 diabetes
    Soderlund, J.
    Forsblom, C.
    Ilonen, J.
    Thorn, L. M.
    Waden, J.
    Parkkonen, M.
    Groop, P-H
    DIABETOLOGIA, 2012, 55 (11) : 2963 - 2969
  • [45] Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus
    A. Imagawa
    T. Hanafusa
    Y. Uchigata
    A. Kanatsuka
    E. Kawasaki
    T. Kobayashi
    A. Shimada
    I. Shimizu
    T. Maruyama
    H. Makino
    Diabetologia, 2005, 48 : 294 - 300
  • [46] Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus
    A. Imagawa
    T. Hanafusa
    Y. Uchigata
    A. Kanatsuka
    E. Kawasaki
    T. Kobayashi
    A. Shimada
    I. Shimizu
    T. Maruyama
    H. Makino
    Diabetologia, 2008, 51 : 524 - 526
  • [47] Inhibitory KIRS decrease HLA class II-mediated protection in type 1 diabetes
    Mora-Bitria, Laura
    McQuibban, Nicholas A. R.
    Niederalt, Christoph
    Asquith, Becca
    HLA, 2022, 99 (05) : 423 - 424
  • [48] HLA class II is a factor in cardiovascular morbidity and mortality rates in patients with type 1 diabetes
    J. Söderlund
    C. Forsblom
    J. Ilonen
    L. M. Thorn
    J. Wadén
    M. Parkkonen
    P.-H. Groop
    Diabetologia, 2012, 55 : 2963 - 2969
  • [49] HLA class II alleles in Norwegian patients with coexisting type 1 diabetes and celiac disease
    Viken, M. K.
    Flam, S. T.
    Skrivarhaug, T.
    Amundsen, S. S.
    Sollid, L. M.
    Drivvoll, A. K.
    Joner, G.
    Dahl-Jorgensen, K.
    Lie, B. A.
    HLA, 2017, 89 (05) : 278 - 284
  • [50] Family-based association study of HLA class II with type 1 diabetes in Moroccans
    Bourhanbour, A. Drissi
    Benseffaj, N.
    Ouadghiri, S.
    Razine, R.
    Touzani, A.
    Belafraj, A.
    Essakalli, M.
    PATHOLOGIE BIOLOGIE, 2015, 63 (02): : 80 - 84